Title The importance of early diagnosis and intervention in chronic kidney disease: calls-to-action from nephrologists based mainly in Central/Eastern Europe /
Authors Covic, Adrian ; Säemann, Marcus ; Filipov, Jean ; Gellert, Ryszard ; Gobin, Niels ; Jelaković, Bojan ; Kabulbayev, Kairat ; Luman, Merike ; Miglinas, Marius ; Mosenzon, Ofri ; Okša, Adrián ; Radovic, Milan ; Rozen-Zvi, Benaya ; Ziediņa, Ieva ; Tesar, Vladimir
DOI 10.1159/000538165
Full Text Download
Is Part of Kidney and blood pressure research.. Basel : S. Karger AG. 2024, vol. 49, iss. 1, p. 218-227.. ISSN 1420-4096. eISSN 1423-0143
Keywords [eng] call-to-action ; Central Europe ; chronic kidney disease ; Eastern Europe ; primary care
Abstract [eng] Background: Chronic kidney disease (CKD) has a global prevalence of 9.1?13.4%. Comorbidities are abundant and may cause and affect CKD. Cardiovascular disease strongly correlates with CKD, increasing the burden of both diseases. Summary: As a group of 15 clinical nephrologists primarily practicing in 12 Central/Eastern European countries, as well as Israel and Kazakhstan, herein we review the significant unmet needs for patients with CKD and recommend several key calls-to-action. Early diagnosis and treatment are imperative to ensure optimal outcomes for patients with CKD, with the potential to greatly reduce both morbidity and mortality. Lack of awareness of CKD, substandard indicators of kidney function, suboptimal screening rates, and geographical disparities in reimbursement often hamper access to effective care. Key Messages: Our key calls-to-action to address these unmet needs, thus improving the standard of care for patients with CKD, are the following: increase disease awareness, such as through education; encourage provision of financial support for patients; develop screening algorithms; revisit primary care physician referral practices; and create epidemiological databases that rectify the paucity of data on early-stage disease. By focusing attention on early detection, diagnosis, and treatment of highrisk and early-stage CKD populations, we aim to reduce the burdens, progression, and mortality of CKD. ? 2024 The Author(s). Published by S. Karger AG, Basel.
Published Basel : S. Karger AG
Type Journal article
Language English
Publication date 2024
CC license CC license description